Concepedia

Göran Wahlund

GW

Statistics

Publications

4

Citations

133

H-Index

4

Active since

1990

Affiliations

AstraZeneca (Sweden)(Current)

Göran Wahlund is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacodynamics.

Publications per year

1990–2014

4

Publications

4

The Fab-fragment of a PAI-1 Inhibiting Antibody Reduces Thrombus Size and Restores Blood Flow in a Rat Model of Arterial Thrombosis

J.J.J. van Giezen, Göran Wahlund, Viveca Nerme et al. · Thrombosis and Haemostasis · 1997 · 51 citations

, , +12

Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein–Protein Interaction

Leifeng Cheng, Daniel Pettersen, Bengt Ohlsson et al. · ACS Medicinal Chemistry Letters · 2014 · 38 citations · Full text

, , +13

The β<sub>1</sub> and β<sub>2</sub>‐adrenoceptor affinity and β<sub>1</sub>‐blocking potency of S‐ and R‐metoprolol

Göran Wahlund, Viveca Nerme, Tommy Abrahamsson et al. · British Journal of Pharmacology · 1990 · 31 citations · Full text

, , +13

Extracellular-Superoxide Dismutase Type C (EC-SOD C) Reduces Myocardial Damage in Rats Subjected to Coronary Occlusion and 24 Hours of Reperfusion

Göran Wahlund, Stefan L. Marklund, Per‐Ove Sjöquist · Free Radical Research Communications · 1992 · 13 citations

, , +16

1–4 of 4